Zacks Research Research Analysts Lift Earnings Estimates for Henry Schein, Inc. (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at Zacks Research raised their Q2 2024 earnings per share estimates for shares of Henry Schein in a research report issued on Wednesday, May 1st. Zacks Research analyst U. Biswas now forecasts that the company will earn $1.27 per share for the quarter, up from their prior estimate of $1.26. The consensus estimate for Henry Schein’s current full-year earnings is $5.07 per share. Zacks Research also issued estimates for Henry Schein’s Q1 2025 earnings at $1.34 EPS.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The business had revenue of $3.02 billion during the quarter, compared to analyst estimates of $3 billion. During the same quarter in the prior year, the company earned $1.21 EPS. Henry Schein’s revenue for the quarter was down 10.5% on a year-over-year basis.

Several other analysts also recently weighed in on HSIC. JPMorgan Chase & Co. increased their target price on Henry Schein from $82.00 to $88.00 and gave the company an “overweight” rating in a research note on Wednesday, March 6th. Jefferies Financial Group upped their target price on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research note on Wednesday, March 6th. Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a research report on Monday, February 26th. Evercore ISI increased their target price on shares of Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a research note on Wednesday, February 28th. Finally, TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $81.09.

Henry Schein Trading Up 1.1 %

Henry Schein stock opened at $68.53 on Monday. The company’s fifty day moving average price is $73.22 and its two-hundred day moving average price is $72.32. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00. Henry Schein has a one year low of $60.01 and a one year high of $82.63. The company has a market capitalization of $8.80 billion, a price-to-earnings ratio of 21.76, a PEG ratio of 1.68 and a beta of 0.87.

Insiders Place Their Bets

In related news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Henry Schein news, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total transaction of $216,193.59. Following the completion of the sale, the insider now owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of the company’s stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Institutional Investors Weigh In On Henry Schein

Institutional investors have recently modified their holdings of the business. Aurora Investment Counsel raised its stake in Henry Schein by 0.7% in the third quarter. Aurora Investment Counsel now owns 20,641 shares of the company’s stock valued at $1,533,000 after purchasing an additional 140 shares in the last quarter. Arizona State Retirement System raised its position in shares of Henry Schein by 0.4% in the 4th quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock valued at $2,717,000 after buying an additional 149 shares in the last quarter. Empirical Finance LLC raised its position in shares of Henry Schein by 3.5% in the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock valued at $360,000 after buying an additional 160 shares in the last quarter. Keene & Associates Inc. boosted its position in shares of Henry Schein by 4.0% during the 1st quarter. Keene & Associates Inc. now owns 4,505 shares of the company’s stock worth $340,000 after acquiring an additional 175 shares in the last quarter. Finally, Wahed Invest LLC increased its stake in Henry Schein by 9.2% in the fourth quarter. Wahed Invest LLC now owns 2,222 shares of the company’s stock valued at $168,000 after acquiring an additional 187 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.